Mixed Signals: Japan’s Drug Pricing Policy
Japan’s pharmaceutical market is caught between two competing priorities—controlling rising healthcare costs and maintaining an environment that fosters innovation. While recent drug pricing reforms have introduced incentives for early market entry a...